AzTrials
AzTrials

Humeral Fracture, ProximalNCT03358784

Comparison of Hemi-shoulder Arthroplasty and PHILOS in Treating Three or Four-part Fractures of Proximal Humerus

An observational study of Humeral Fracture, Proximal, run by Peking University People's Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To explore clinical effectiveness of PHILOS plate fixation and hemi-shoulder arthroplasty in treating three or four-part fractures of proximal humerus Read more about this study

Who is it for?
Ages 60 to 85 years
Conditions the study is for
Humeral Fracture, Proximal
What is being tested?
Hemi-shoulder Arthroplasty and PHILOS Plate
Type of treatment
Surgery or procedure
How many people
300 participants
Where
No sites listed yet
Study dates
5 Mar 2018to 1 Mar 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 85 years
  • All sexes
  • Adult, Older adult

Study population: patients with three or four part fractures of proximal humerus, who agreed to receive surgery.

Who may be able to join

  • three or four part fractures of proximal humerus

Who cannot join

  • Severe comminuted fractures of proximal humerus
  • past history of injured-side shoulder surgery
  • Patients who cannot tolerate surgery

Trial locations and contacts

No sites are listed yet.

Yichong Zhang, MD contact

15210802766

875274428@qq.com

About this study

Official title: A Multi-center Study on Comparison of Hemi-shoulder Arthroplasty and PHILOS in Treating Three or Four-part Fractures of Proximal Humerus.

To explore clinical effectiveness of PHILOS plate fixation and hemi-shoulder arthroplasty in treating three or four-part fractures of proximal humerus

Read the detailed description

From April 2015 and April 2017, patients from multi-center aged over 60 years old with three and four-part fractures of proximal humerus were treated with Proximal Humerus Internal Locking System(PHILOS) and hemi-shoulder arthroplasty in multi-center. All the patients received the same rehabilitation course. At 6 months after surgery, postoperative complications were observed, EQ-5D was used to evaluate quality of life, and ASES score was used to assess functional outcomes.

Being tested
Hemi-shoulder Arthroplasty, PHILOS Plate
Keywords
Humeral Fractures, Proximal, Arthroplasty, Shoulder Replacement, Bone Plates
Medical subject headings
Shoulder Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hemi-shoulder ArthroplastyProcedure or surgery

    Hemi-shoulder Arthroplasty treating three or four-part fractures of proximal humerus

  • PHILOS PlateProcedure or surgery

    PHILOS plate treating three or four-part fractures of proximal humerus

Study groups in NCT03358784
Study groupRoleWhat they receive
PHILOS Platethree or four-part fractures of proximal humerus treated with internal fixation
Receives: Procedure: PHILOS Plate
Hemi-shoulder arthroplastythree or four-part fractures of proximal humerus treated with hemi-shoulder arthroplasty
Receives: Procedure: Hemi-shoulder Arthroplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative complications

    Postoperative complications were observed

    Measured: 6 months after surgery

Secondary outcomes (2)
  1. EQ-5D

    EQ-5D was used to evaluate quality of life

    Measured: 6 months after surgery

  2. ASES score

    ASES was used to assess functional outcomes

    Measured: 6 months after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Dec 2017
  2. Study start5 Mar 2018 (estimated)
  3. Primary completion1 Mar 2019 (estimated)
  4. Study completion1 Mar 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03358784
Sponsor's protocol ID
PUPH2017PHF
Status last verified
Nov 2017
First submitted
26 Nov 2017
Last updated
2 Dec 2017
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Humeral Fracture, Proximal, run by Peking University People's Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yichong Zhang, MD (15210802766, 875274428@qq.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative complications (time frame: 6 months after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Dec 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in